Innovation Hub / Podcasts
Weekly News Roundup - Biosimilar Policy Changes, mRNA Leadership Shifts, and Rare Disease Market Growth
March 13, 2026
This week's tHEORetically Speaking News Roundup covers the FDA's new guidance aimed at streamlining biosimilar development and reducing drug costs, leadership changes at BioNTech as its founders step down to launch a new mRNA venture, and projections that the global rare disease drug market could surpass $400 billion by 2032. We also explore the FDA's launch of a new unified adverse event monitoring platform designed to modernize safety surveillance and improve transparency.
Weekly News Roundup - PhRMA Leadership Transition, The ICHRA Shift, and MDUFA VI Preliminary Deal
Talking Real Science with Stella Goulopoulou
Talking Real Science with Yelena Akelina
#ExpertAnswers: Catherine Ewen on Setting Up DC and CD8+ T Cell Co-culture Experiments
Talking Real Science with Licy Yanes Cardozo
Industry Insights with Bas Trietsch and STEMCELL Technologies
Talking Real Science with Helen Collins
Talking Real Science with Rachel Buckley
Talking Real Science with Meaghan Loy on Rare Disease Day